Necrobiotic xanthogranuloma: Difference between revisions
From WikiMD's Medical Encyclopedia
CSV import |
CSV import Tag: Reverted |
||
| Line 70: | Line 70: | ||
{{Cutaneous-condition-stub}} | {{Cutaneous-condition-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 19:39, 17 March 2025
| Necrobiotic xanthogranuloma | |
|---|---|
| [[File:|250px|alt=|]] | |
| Synonyms | NXG<ref>
Necrobiotic xanthogranuloma | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program(link). rarediseases.info.nih.gov.
|
| Pronounce | |
| Field | dermatology |
| Symptoms | |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | |
| Risks | |
| Diagnosis | |
| Differential diagnosis | |
| Prevention | |
| Treatment | |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Alternate names
NXG
Definition
Necrobiotic xanthogranuloma (NXG) is a rare, chronic form of non-Langerhans histiocytosis usually found in older adults. Xanthogranulomas are lesions made of immune cells known as a histiocytes. The term necrobiotic refers to the buildup of broken down collagen fibers that can be seen under a microscope.
Signs and symptoms
- The typical lesion is a yellow, thickened, or raised lesion (plaque) located around the eyes.
- In most cases the lesions are associated with conditions in which abnormal proteins are found in the blood (monoclonal gammopathies).
- NXG is also sometimes associated with blood cancers or lymphoproliferative disorders.
- As these blood disorders may arise years after the first NXG lesions appear, lifelong follow-up may be recommended.
- Approximately 50% of people with NXG have problems with their eyes, such as burning or itching, blurred vision, double vision, bulging of the eyeball, drooping of the eyelid, and restricted eye movement.
- In most cases, other parts of the body, such as the trunk, legs, face, and arms, are also involved.
- Internal organs may sometimes be affected.
Treatment
- Treatment of NXG can be challenging, but is usually necessary to minimize the risk of skin ulcers and scarring.
- First-line therapy may include drugs used to treat cancer (such as chlorambucil and melphalan).
- Additional treatment options include corticosteroids, intravenous immunoglobulin, lenalidomide, interferon, radiation therapy, and surgery. In some cases, the symptoms of NXG may return after treatment.
- If NXG is associated with a blood cancer or a lymphoproliferative disorder, treatment focuses on the blood disorder.
See also
External links